Ngā hua rapu kaituhi

1

GFAP: Functional implications gleaned from studies of genetically engineered mice mā Albee Messing, Michael Brenner

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

GFAP at 50 mā Albee Messing, Michael Brenner

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Regulation of GFAP Expression mā Michael Brenner, Albee Messing

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Dysfunctions of neuronal and glial intermediate filaments in disease mā Ronald K.H. Liem, Albee Messing

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Determinants of Excitability at Transition Zones in Kv1.1-Deficient Myelinated Nerves mā L. Zhou, Albee Messing, Shing Yan Chiu

I whakaputaina 1999

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Conditional Ablation of Cerebellar Astrocytes in Postnatal Transgenic Mice mā Catherine L. Delaney, Michael Brenner, Albee Messing

I whakaputaina 1996

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Deficits in Adult Neurogenesis, Contextual Fear Conditioning, and Spatial Learning in a<i>Gfap</i>Mutant Mouse Model of Alexander Disease mā Tracy L. Hagemann, Richard Paylor, Albee Messing

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Genotype-Phenotype Association for 14 <i>GFAP</i> Variants in Alexander Disease mā Albee Messing, Amy Waldman, Daniel M. Bolt

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice mā JS Cole, Albee Messing, JQ Trojanowski, VM Lee

I whakaputaina 1994

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Alexander Disease-Associated Glial Fibrillary Acidic Protein Mutations in Mice Induce Rosenthal Fiber Formation and a White Matter Stress Response mā Tracy L. Hagemann, Jolien X. Connor, Albee Messing

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

GFAP Expression as an Indicator of Disease Severity in Mouse Models of Alexander Disease mā Paige L. Jany, Tracy L. Hagemann, Albee Messing

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Temperature-Sensitive Neuromuscular Transmission in Kv1.1 Null Mice: Role of Potassium Channels under the Myelin Sheath in Young Nerves mā L. Zhou, Chuan-Li Zhang, Albee Messing, Shing Yan Chiu

I whakaputaina 1998

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

GFAP promoter directs astrocyte-specific expression in transgenic mice mā Michael Brenner, WC Kisseberth, Yuan Su, F. Besnard, Albee Messing

I whakaputaina 1994

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Strategies for Treatment in Alexander Disease mā Albee Messing, Christine M. LaPash Daniels, Tracy L. Hagemann

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
15

GFAP and its role in Alexander disease mā Roy A. Quinlan, Michael Brenner, James E. Goldman, Albee Messing

I whakaputaina 2007

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
16

Suppression of GFAP toxicity by αB-crystallin in mouse models of Alexander disease mā Tracy L. Hagemann, Wilbert C. Boelens, Eric F. Wawrousek, Albee Messing

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Alexander Disease mā Albee Messing, Michael Brenner, Mel Β. Feany, Maiken Nedergaard, James E. Goldman

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Transgenic mice express the human phenylethanolamine N-methyltransferase gene in adrenal medulla and retina. mā E. Edward Baetge, Richard R. Behringer, Albee Messing, Ralph L. Brinster, R D Palmiter

I whakaputaina 1988

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis mā Marcelo R. Vargas, Delinda A. Johnson, Daniel W. Sirkis, Albee Messing, Jeffrey A. Johnson

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization mā Qing Yue, Matthias Groszer, Jose S. Gil, Arnold Berk, Albee Messing, Hong Wu, Xin Liu

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Albee Messing

GFAP: Functional implications gleaned from studies of genetically engineered mice mā Albee Messing, Michael Brenner

GFAP at 50 mā Albee Messing, Michael Brenner

Regulation of GFAP Expression mā Michael Brenner, Albee Messing

Dysfunctions of neuronal and glial intermediate filaments in disease mā Ronald K.H. Liem, Albee Messing

Determinants of Excitability at Transition Zones in Kv1.1-Deficient Myelinated Nerves mā L. Zhou, Albee Messing, Shing Yan Chiu

Conditional Ablation of Cerebellar Astrocytes in Postnatal Transgenic Mice mā Catherine L. Delaney, Michael Brenner, Albee Messing

Deficits in Adult Neurogenesis, Contextual Fear Conditioning, and Spatial Learning in a<i>Gfap</i>Mutant Mouse Model of Alexander Disease mā Tracy L. Hagemann, Richard Paylor, Albee Messing

Genotype-Phenotype Association for 14 <i>GFAP</i> Variants in Alexander Disease mā Albee Messing, Amy Waldman, Daniel M. Bolt

Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice mā JS Cole, Albee Messing, JQ Trojanowski, VM Lee

Alexander Disease-Associated Glial Fibrillary Acidic Protein Mutations in Mice Induce Rosenthal Fiber Formation and a White Matter Stress Response mā Tracy L. Hagemann, Jolien X. Connor, Albee Messing

GFAP Expression as an Indicator of Disease Severity in Mouse Models of Alexander Disease mā Paige L. Jany, Tracy L. Hagemann, Albee Messing

Temperature-Sensitive Neuromuscular Transmission in Kv1.1 Null Mice: Role of Potassium Channels under the Myelin Sheath in Young Nerves mā L. Zhou, Chuan-Li Zhang, Albee Messing, Shing Yan Chiu

GFAP promoter directs astrocyte-specific expression in transgenic mice mā Michael Brenner, WC Kisseberth, Yuan Su, F. Besnard, Albee Messing

Strategies for Treatment in Alexander Disease mā Albee Messing, Christine M. LaPash Daniels, Tracy L. Hagemann

GFAP and its role in Alexander disease mā Roy A. Quinlan, Michael Brenner, James E. Goldman, Albee Messing

Suppression of GFAP toxicity by αB-crystallin in mouse models of Alexander disease mā Tracy L. Hagemann, Wilbert C. Boelens, Eric F. Wawrousek, Albee Messing

Alexander Disease mā Albee Messing, Michael Brenner, Mel Β. Feany, Maiken Nedergaard, James E. Goldman

Transgenic mice express the human phenylethanolamine N-methyltransferase gene in adrenal medulla and retina. mā E. Edward Baetge, Richard R. Behringer, Albee Messing, Ralph L. Brinster, R D Palmiter

Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis mā Marcelo R. Vargas, Delinda A. Johnson, Daniel W. Sirkis, Albee Messing, Jeffrey A. Johnson

PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization mā Qing Yue, Matthias Groszer, Jose S. Gil, Arnold Berk, Albee Messing, Hong Wu, Xin Liu

Ngā utauta rapu:

Ngā marau whai pānga